Characterization of the CXCR4 signaling in pancreatic cancer cells

Daniel D. Billadeau, Subrha Chatterjee, Patricia Bramati, Raghavakaimal Sreekumar, Vijay Shah, Karen Hedin, Raul Urrutia

Research output: Contribution to journalArticlepeer-review

47 Scopus citations


CXCL12 and its receptor, CXCR4, are emerging as promising targets for modulating growth, angiogenesis, and metastasis in several human cancers. Indeed, blocking the receptor is sufficient to prevent metastasis and angiogenesis in experimental breast cancer xenografts. Recently, the biological effect of the CXCR4 in pancreatic cancer, one of the most deadly neoplastic diseases, has been reported. However, the molecular mechanism by which CXCR4 contributes to these properties is not completely understood. In this paper, we characterize the signaling pathways activated by CXCR4 in pancreatic cancer. We show that after CXCR4 activation, EGFR becomes tyrosine phosphorylated, and the kinase activity of this receptor, together with the activation of MMPs, Src, and PI3-Kinase, is required for CXCR4-mediated ERK activation. Analysis of this cascade in pancreatic cancer cells revealed that the ERK-mediated pathway regulates genes involved in angiogenesis, such as VEGF, CD44, HIF1α, and IL-8. Furthermore, ERK blockage inhibits the migration and tube formation of endothelial cells induced by CXCL12. Considering that inhibitors for several components of this pathway, including CXCR4 itself, are at different stages of clinical trials, this study provides theoretical justification for the clinical testing of these drugs in pancreatic cancer, thus extending the list of potential targets for treating this dismal disease.

Original languageEnglish (US)
Pages (from-to)110-119
Number of pages10
JournalInternational Journal of Gastrointestinal Cancer
Issue number4
StatePublished - Dec 2006


  • Angiogenesis
  • CXCL12
  • CXCR4
  • ERK
  • Pancreatic cancer

ASJC Scopus subject areas

  • Oncology
  • Endocrinology
  • Gastroenterology


Dive into the research topics of 'Characterization of the CXCR4 signaling in pancreatic cancer cells'. Together they form a unique fingerprint.

Cite this